The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant trastuzumab (H), pertuzumab (P), and chemotherapy versus trastuzumab emtansine (T-DM1) and P in human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC): Final outcome results from the phase III KRISTINE study.
Sara A. Hurvitz
Research Funding - Ambryx (Inst); Amgen (Inst); Bayer (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); Daiichi Sankyo (Inst); Dignitana (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Medivation (Inst); Merrimack (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Puma Biotechnology (Inst); sanofi (Inst); Seattle Genetics (Inst)
Travel, Accommodations, Expenses - Lilly; Novartis; OBI Pharma
Miguel Martin
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; PharmaMar; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Novartis (Inst); Roche (Inst)
Kyung Hae Jung
No Relationships to Disclose
Chiun-Sheng Huang
Honoraria - Amgen; AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Pfizer; Roche
Speakers' Bureau - Amgen; Pfizer; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Pfizer; Roche
Nadia Harbeck
Honoraria - Amgen; Celgene; Genomic Health; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - Agendia; AstraZeneca; Celgene; Daiichi Sankyo; Lilly; Merck Sharp & Dohme; Novartis; Odonate Therapeutics; Pfizer; Roche/Genentech; Sandoz; Seattle Genetics
Research Funding - Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Vicente Valero
No Relationships to Disclose
Daniil Stroyakovskiy
No Relationships to Disclose
Hans Wildiers
Honoraria - Amgen; Novartis; Roche
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); Roche (Inst); Vifor Pharma (Inst)
Research Funding - Roche (Inst)
Expert Testimony - Abbvie; TRM Oncology
Travel, Accommodations, Expenses - Pfizer; Puma Biotechnology; Roche; TRM Oncology
Mario Campone
Honoraria - Menarini; Novartis; Servier
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Lilly (Inst); Menarini; Novartis (Inst); Pfizer (Inst); Sanofi (Inst); SERVIER (Inst)
Speakers' Bureau - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Roche
Jean-Francois Boileau
Consulting or Advisory Role - Genomic Health; Lilly; Roche
Speakers' Bureau - Allergan; Genomic Health; Novartis; Pfizer; Roche
Research Funding - Abbvie (Inst); Genomic Health (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lifecell Corporation; Roche
Matthias W. Beckmann
Stock and Other Ownership Interests - Instituts für Frauengesundheit GmbH
Karen Afenjar
Travel, Accommodations, Expenses - Novartis
Gonzalo Spera
No Relationships to Disclose
Vanesa Lopez Valverde
Employment - Roche
Honoraria - Roche
Travel, Accommodations, Expenses - Roche
Chunyan Song
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Thomas Boulet
Employment - PAREXEL
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - Adgero Biopharmaceuticals; AstraZeneca; Cardinal Health; Celgene; Celldex; Genentech/Roche; Juno Therapeutics; Lilly; Merrimack; Novartis; Pfizer; Prescient Therapeutics
Research Funding - Deciphera (Inst); Genentech/Roche (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Novartis (Inst); Prescient Therapeutics (Inst); Radius Health (Inst)
Travel, Accommodations, Expenses - Adgero Biopharmaceuticals; AstraZeneca; Menarini Silicon Biosystems; Myriad Genetics; Pfizer; Roche/Genentech
William Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; ISIS Pharmaceuticals; Nuvera Biosciences
Consulting or Advisory Role - Almac Diagnostics; Merck
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired)
Travel, Accommodations, Expenses - Luminex; Merck
Alastair Mark Thompson
Honoraria - Novartis (I); Pfizer
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Novartis (I); Pfizer
Dennis J. Slamon
Leadership - Biomarin
Stock and Other Ownership Interests - Pfizer
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Novartis
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Biomarin; Novartis; Pfizer